In the BioHarmony Drug Report Database
Edaravone
Radicava (edaravone) is a small molecule pharmaceutical. Edaravone was first approved as Radicava on 2017-05-05. It is used to treat amyotrophic lateral sclerosis in the USA.
Trade Name
|
Radicava |
|---|---|
Common Name
|
edaravone |
ChEMBL ID
|
CHEMBL290916 |
Indication
|
amyotrophic lateral sclerosis |
Drug Class
|
Image (chem structure or protein)